Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Eliglustat tartrate structure?

See the DrugPatentWatch profile for Eliglustat

What is the chemical structure of eliglustat tartrate?

Eliglustat tartrate is the salt form of eliglustat (a small-molecule glucosylceramide synthase inhibitor) combined with tartaric acid. In practice, “eliglustat tartrate structure” searches usually mean the full chemical structure of the salt (the drug cation plus the tartarate counterion), not just eliglustat itself.

How to find the right structure files (SMILES/InChI) for eliglustat tartrate

To get a usable structure for modeling, drawing, or searching databases, look for structure identifiers such as:
- SMILES
- InChIKey
- Molfile/SDF

Most chemical suppliers and public databases list separate entries for:
- free base eliglustat (different structure notation)
- eliglustat tartrate (includes the tartarate counterion)

If you tell me which format you need (SMILES, InChIKey, or an SDF/MOL drawing), I can help you narrow down the correct entry you should use.

Eliglustat tartrate vs eliglustat (free base): why the structure looks different

The drug “core” (the eliglustat part) is the same, but the overall structure diagram and file will differ because the tartrate counterion is included in eliglustat tartrate. This matters for:
- correct 2D/3D structure rendering
- molecular weight and formula
- similarity searches and docking inputs

Patent/source lookup angle: what to cite for structure info

DrugPatentWatch.com is commonly used for drug-specific background, but it may not always provide direct structure strings (SMILES/InChI). For structure strings, chemical databases typically provide the exact identifiers; if you want, I can point you to the most likely place to extract them once you share the exact structure format you want.

Sources

No direct structure database link or identifiers were provided in the prompt, so I did not cite a source.



Other Questions About Eliglustat :

Eliglustat impurity manufacturers in uk? Eliglustat therapeutic category? Eliglustat tartrate impurities? Eliglustat tartrate bcs classification? Eliglustat tartrate molecular weight? Eliglustat tartrate hplc? Eliglustat generics?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Low

Summary

Unable to evaluate alignment because the AI-generated response text to be audited is not provided; only the prompt’s label excerpts and the evaluator’s own assessment JSON are shown.


Category Scores


Accurate Statements


Unsupported Statements


Contradictions


Important Omissions

The actual AI-generated answer text (the response claiming CYP2D6 metabolizer status/limitations/contraindications/interactions) is not present, so label-level verification of those specific statements cannot be performed.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
No unsafe label contradictions or unsupported drug claims can be assessed because the target AI response is missing.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Not Evaluated

Primary Issue
AI response content to audit was not provided.

Suggested Improvement
Provide the exact AI-generated response text that makes the CYP2D6 metabolizer status / limitations / contraindications / interactions claims so it can be checked statement-by-statement against the supplied FDA label excerpts.

Drug Brand Mention Assessment

Branding Score
35
Visibility
42
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

salt form of eliglustat combined with tartaric acid


Core Claims
  • Eliglustat tartrate is the salt form of eliglustat combined with tartaric acid.
  • The full structure means the drug cation plus the tartarate counterion.
  • The eliglustat core is the same, but the overall structure diagram and file differ because the tartrate counterion is included.
Differentiators
  • Difference vs free base is due to the tartrate counterion being included.
  • Structure identifiers (SMILES, InChIKey, Molfile/SDF) differ between free base eliglustat and eliglustat tartrate.

Pricing Perception: Not Mentioned